Skip to content

High-intensity Interval Exercise in Rheumatoid Arthritis

Expected Health Benefits on Cardiovascular Function, Inflammation and Quality of Life With High-intensity Interval Exercise for Patients With Rheumatoid Arthritis

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05768165
Acronym
RA-HIIT
Enrollment
87
Registered
2023-03-14
Start date
2021-08-16
Completion date
2026-12-30
Last updated
2025-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Brief summary

Cardiovascular performance and overall fitness can be improved by high-intensity aerobic activity, and these benefits may be achievable by persons with rheumatic diseases. The investigators hypothesize that a 12-week high-intensity interval exercise program will provide substantial improvements in cardiovascular function, inflammation and symptoms affecting quality of life.

Interventions

BEHAVIORALHigh intensity exercise

Twelve weeks of supervised high intensity aerobic and resistance exercise including two sessions/week, one additional session of the patient´s own choice, non-supervised. The target of the high intensity intervals (HIIT) is 90%-95% of maximum heart rate alternated with recovery phases at 70% of maximal heart rate. The resistance exercise session of large muscle groups: 8-10 repetitions, 2-3 sets. Exercise guidance follows principles of self-efficacy and person-centeredness.

Sponsors

Göteborg University
CollaboratorOTHER
Vastra Gotaland Region
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Single blinded

Intervention model description

Intervention versus care as usual

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Rheumatoid arthritis disease according to the American College of Rheumatology (ACR)/ The European Alliance of Associations for Rheumatology (EULAR) 1987/2010 criteria * Disease duration \>1 year * Age (range 20-60 years) * Stable medication on anti- rheumatic drugs for \>3 months * Low-to-moderate disease activity (\<5.1) according to the Disease activity score 28 (DAS28)

Exclusion criteria

* Cerebrovascular diseases * Diabetes * Severe hypertension * Chronic obstructive pulmonary disease or other severe pulmonary diseases * Other severe diseases that may be associated with adverse events or restrict participation in high-intensity exercise * Arthroplasty of large joints * Inability to manage Cardiopulmonary Exercise Testing (CPET) * Pregnancy * Already participating in regular aerobic or strength exercise at a high intensity level (\>1 hours/ week) during the last 6 months * Inability to speak or read Swedish.

Design outcomes

Primary

MeasureTime frameDescription
Cardiopulmonary function0 -12 weeksMaximum oxygen uptake (VO2ml/min/kg) (Higher value indicate better cardiorespiratory capacity)

Secondary

MeasureTime frameDescription
Erythrocyte Sedimentation Rate (ESR)0-12 weeksLevel of high sensitivity ESR (mm/h) (Higher score indicate higher inflammation)
Vascular function0-12 weeksAortic pulse wave velocity (PWV) (m/sec.) (Higher PWV value indicate worse vascular function)
Level of disease activity0-12 weeksDisease activity score 28 (DAS28) (Range 0-10 where a higher score indicate worse disease activity)
Homeostatic model assessment of insulin resistance (HOMA IR)0-12 weeksMeasure of insulin resistance (fasting glucose (mmol/L) and fasting insulin (mIU/ L) will be combined to report HOMA IR
Glycosylation level of hemoglobin (HbA1c)0-12 weeksGlycosylation level of hemoglobin (mmol/mol)
C-Reactive Protein (CRP)0-12 weeksLevel of high sensitivity CRP (mg/L) (Higher score indicate higher inflammation)
Cytokine levels0-12 weeksInterleukin-6 (pg/mL), interleukin-10 (pg/mL), tumour necrosis factor-alpha (pg/mL)
Muscle function of lower extremities0-12 weeksThe one minute sit-to-stand test (Higher numbers of complete rises indicate better muscle function in lower extremities)
Hand-grip force0-12 weeksHand-grip force is assessed with a dynamometer ( Higher value indicate better grip strength)
Level of blood lipids0-12 weeksLevels of triglycerides (mmol/L), Level of high-density lipoprotein (HDL) (mmol/L), low-density lipoprotein (LDL) ( mmol/L), Total cholesterol (mmol/L )
Objective assessment of physical activity0-12 weeksAccelerometer to assess habitual physical activity during a typical week. Total time of physical activity and physical activity pattern assessed as time spent at different physical activity intensity levels are obtained using the metabolic equivalent of task values (METS). (Higher METs value indicate higher physical activity level.)
Pain intensity0-12 weeksVisual Analogue Scale (VAS) (0-100, Higher score indicate worse pain)
Global health0-12 weeksVisual Analogue Scale (VAS) (0-100, Higher score indicate worse health)
Fatigue0-12 weeksThe Multiple Fatigue Inventory (MFI-20) (4-20 for each subscale, Higher score indicates a higher degree of fatigue
Sleep0-12 weeksPittsburgh Sleep Quality Index (0-21, Higher score indicate worse sleep quality).
Activity limitations0-12 weeksHealth Assessment Questionnaire (HAQ) (0-3, Higher score indicate worse activity limitations)
Attitude to exercise0-12 weeksExercise Health Beliefs questionnaire (20-100, Higher score represents stronger exercise health beliefs.
Body compositions0-12 weeksWeight and height will be combined to report Body mass index BMI kg/m2 (A higher score indicate higher relative weight)
Waist circumference0-12 weeksMeasured with a tape measure midway between the lower rib and iliac crest. (A waist measurement of 80 centimeters or more for women and 94 centimeters or more for men indicate increased risk for diseases related to overweight)
Self-reported physical activity0-12 weeksSelf-reported questionnaire of habitual physical activity during a typical week. Numbers of hours on low, moderate and high intensity is summed for each category (A minimum of 150 minutes on moderate intensity or 75 minutes on high intensity are equal to health enhancing physical activity according to World Health Organization guidelines)

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026